← Back to Search

Behavioral Health Navigation for Mental Illness in Black Youth

N/A
Recruiting
Led By Mary M McKay, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of one year
Awards & highlights

Study Summary

This trial will test if providing a child behavioral health navigator to 390 early adolescent youth of African descent living in St. Louis will reduce racial disparities in mental health care.

Who is the study for?
This trial is for early adolescent youth of African descent, aged 10 to 14, showing signs of disruptive behaviors or ADHD. They must be willing to participate and have an adult caregiver who can consent. Adults over 21 from the community with relevant experience are also eligible.Check my eligibility
What is being tested?
The study tests a Child Behavioral Health Navigator intervention against standard care. Navigators will support families in St. Louis neighborhoods by providing engagement, education, and assistance tailored to improve mental health outcomes for black youth.See study design
What are the potential side effects?
Since this trial involves behavioral interventions rather than medications, there aren't typical drug side effects; however, participants may experience emotional discomfort or stress during the process.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of one year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Beliefs about Mental Illness (BMI) Scale
Disruptive Behavior Disorder Rating Scale (DBDRS)
Electronic Medical Record Abstractions
+7 more
Secondary outcome measures
Implementation and Feasibility Checklists
Program Sustainability Assessment Tool (PSAT)
Project Reach Care and System Tracking Tools
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Child Behavioral Health Navigators (cbhN)Experimental Treatment1 Intervention
CbhNs will engage in a series of face to face and phone contacts with families to coordinate needed appointments at mental health care sites, as well as a range of human service support organizations (e.g. housing, food, financial, legal assistance). Over time, contact may decrease as the youth/family make ongoing connection with mental health care and other resources. However, over the course of the study (twelve months), twice per month check-ins will be routine between cbhNs and families. In addition, the cbhN will be expected to actively engage with the range of service providers and mental health resources as needed and preferred by the family. These contacts include telephone linkage calls, in-person advocacy meetings and at time, accompanying the youth and families to meetings at each organization.
Group II: Standard CareActive Control1 Intervention
Standard care will consist of 1) community-based screening and referral and 2) monthly contacts by a case manager, who will track attendance in mental health services and provide referrals upon request.

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,937 Previous Clinical Trials
2,299,297 Total Patients Enrolled
1 Trials studying Oppositional Defiant Disorder
144 Patients Enrolled for Oppositional Defiant Disorder
Mary M McKay, PhDPrincipal InvestigatorWashington University School of Medicine
1 Previous Clinical Trials
96 Total Patients Enrolled

Media Library

Child Behavioral Health Navigator (cbhN) Clinical Trial Eligibility Overview. Trial Name: NCT04113161 — N/A
Oppositional Defiant Disorder Research Study Groups: Standard Care, Child Behavioral Health Navigators (cbhN)
Oppositional Defiant Disorder Clinical Trial 2023: Child Behavioral Health Navigator (cbhN) Highlights & Side Effects. Trial Name: NCT04113161 — N/A
Child Behavioral Health Navigator (cbhN) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04113161 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are involved with this clinical trial?

"Affirmative, the public record from clinicaltrials.gov confirms that this trial is still recruiting suitable research participants. It was posted on January 1st 2020 and last updated on April 13th 2022; 405 individuals are required for a single site study."

Answered by AI

What is the primary goal of this experiment?

"This medical trial is primarily focused on assessing the change in Disruptive Behavior Disorders symptoms from 3 months to 12 months post-intervention, which will be measured using Metropolitan Area Child Study (MACS) Process Records. Secondary objectives include Implementation and Feasibility Checklists as well Program Sustainability Assessment Tool (PSAT), composed of 40 items distributed along a 7-point Likert scale; Texas Christian University (TCU) Survey of Organizational Functioning, which includes 129 questions rated with 5 levels of agreement ranging from "strongly disagree" to "strongly agree"."

Answered by AI

Are there any unreserved opportunities to participate in this clinical investigation?

"Affirmative. The findings from clinicaltrials.gov verify that this experiment, established on January 1st 2020, is presently recruiting volunteers. Approximately 405 participants must be sourced from a single location."

Answered by AI
~8 spots leftby May 2024